Working… Menu

Phase 1 Study of ELX-02 in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03292302
Recruitment Status : Completed
First Posted : September 25, 2017
Last Update Posted : October 22, 2019
SGS Life Sciences, a division of SGS Belgium NV
Information provided by (Responsible Party):
Eloxx Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 15, 2017
Actual Study Completion Date : December 15, 2017